(Q48404656)

11 February 2018

title

The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas. (English)

1 reference

11 February 2018

4

Bartenstein P

1 reference

11 February 2018

author name string

Gross MW

1

1 reference

11 February 2018

Weber WA

2

1 reference

11 February 2018

Feldmann HJ

3

1 reference

11 February 2018

Schwaiger M

5

1 reference

11 February 2018

Molls M

6

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

11 February 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

11 February 2018

volume

41

1 reference

11 February 2018

page(s)

989-995

1 reference

11 February 2018

issue

5

1 reference

11 February 2018

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

Long-term survival in patients with malignant astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

Intratumoral histologic heterogeneity of gliomas. A quantitative study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

Positron emission tomography in patients with glioma. A predictor of prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

Positron emission tomography and in vivo measurements of tumour perfusion and oxygen utilisation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

The use of PET in evaluating patients with primary brain tumours: is it useful?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

Head fixation device for reproducible position alignment in transmission CT and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

[3-Dimensional irradiation planning in brain tumors. The advantages of the method and the clinical results].

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

Patterns of recurrence of malignant astrocytoma following stereotactic interstitial brachytherapy with iodine-125 implants.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

Patterns of second recurrence of malignant astrocytomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2898%2900183-7

7 January 2021

10.1016/S0360-3016(98)00183-7

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9719107

1 reference

11 February 2018